Hanmi Pharm, International Certification for Business Continuity Management System

Woo Jong-su, CEO of Hanmi Pharmaceutical (left), and Lee Il-hyung, CEO of Lloyd Certification Institute, are posing for a commemorative photo after the certificate awarding ceremony on the 8th.

[Asia Economy Reporter Choi Dae-yeol] Hanmi Pharm announced on the 9th that it has received the international standard ISO22301 certification for business continuity management systems from Lloyd's Register, a UK-based global certification body.

This certification is one of the international standards enacted by the International Organization for Standardization (ISO) in May 2012. It evaluates the ability to restore business operations to normal within the shortest possible time in case of unexpected work interruptions caused by various accidents or disasters. The company obtained certification for both manufacturing processes and general business areas. Among domestic pharmaceutical companies, Samsung Biologics was the only one in the bio industry to receive this certification in 2018.

With this certification, Hanmi Pharm Group has secured a total of seven international standard certifications, the most in the domestic pharmaceutical industry. Woo Jong-su, CEO of Hanmi Pharm, stated, "Hanmi Pharm is preparing for various potential crises and is providing high-quality and safe pharmaceuticals stably to patients and medical staff."

This content was produced with the assistance of AI translation services.